Financials
- Market Capitalization 289.77 M
- Employee 28
- Founded 2018
- CEO N/A
- Website www.opusgtx.com
- Headquarter Delaware, United States
- FIGI BBG000BT34Q3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.51
ratio cours/chiffre d'affaires
8.81
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3356 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.59 USD | -0.63% | -8.09% | +70.97% | +23.26% | 294.60 M USD | ||
| 3361 | INDP Indaptus Therapeutics, Inc. - Common Stock | 2.60 USD | -1.14% | -2.62% | -28.18% | +36.84% | 294.43 M USD | ||
| 3388 | TTRX Turn Therapeutics Inc. - Common Stock | 9.59 USD | +1.27% | -1.24% | +55.18% | -4.10% | 285.67 M USD | ||
| 3389 | MGNX MacroGenics, Inc. - Common Stock | 4.30 USD | -4.44% | -9.47% | +8.59% | +173.89% | 273.32 M USD |